Oryzon Genomics S.A. - Product Pipeline Analysis, 2015 Update

Date: July 22, 2015
Pages: 27
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O366CC0C8D8EN
Leaflet:

Download PDF Leaflet

Oryzon Genomics S.A. - Product Pipeline Analysis, 2015 Update
Summary

Oryzon Genomics S.A. (Oryzon) is a biopharmaceutical company that develops therapies and biological solutions for cancer and neurodegenerative diseases. The company concentrates on the exploitation of biomarkers identified through genomics and proteomics in diagnostics, personalized medicine and therapy fields. Oryzon’s diagnostic products include GynEC-DX for endometrial cancerCxbladder for bladder cancerand ColoBRAF for colorectal cancer. It produces NCEs and monoclonal antibodies for neurogeneration and cancer. The company integrates different platforms such as Genomics, Bioinformatics, Target validation and Development of new biochemical, among others. Oryzon is headquartered in Barcelona, Spain.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Oryzon Genomics S.A.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Oryzon Genomics S.A. Company Snapshot
Oryzon Genomics S.A. Company Overview
Key Information
Oryzon Genomics S.A. Pipeline Products and Clinical Trials Overview
Oryzon Genomics S.A. – Pipeline Analysis Overview
Key Facts
Oryzon Genomics S.A. - Major Products and Services
Oryzon Genomics S.A. Pipeline Products by Development Stage
Oryzon Genomics S.A. Pipeline Products Overview
Diagnostic Assay - Alzheimer's Disease
Diagnostic Assay - Alzheimer's Disease Product Overview
Diagnostic Assay - Gastric Cancer
Diagnostic Assay - Gastric Cancer Product Overview
Diagnostic Assay - Melanoma Cancer
Diagnostic Assay - Melanoma Cancer Product Overview
Diagnostic Assay - Parkinson's Disease
Diagnostic Assay - Parkinson's Disease Product Overview
Diagnostic Assay - Stomach Cancer
Diagnostic Assay - Stomach Cancer Product Overview
Oryzon Diagnostic Test - Prostate Cancer
Oryzon Diagnostic Test - Prostate Cancer Product Overview
Prognostic Assay - Gastric Cancer
Prognostic Assay - Gastric Cancer Product Overview
Prognostic Assay - Melanoma Cancer
Prognostic Assay - Melanoma Cancer Product Overview
Prognostic Assay - Ovarian Cancer
Prognostic Assay - Ovarian Cancer Product Overview
Prognostic Test - Colorectal Cancer
Prognostic Test - Colorectal Cancer Product Overview
Oryzon Genomics S.A. - Key Competitors
Oryzon Genomics S.A. - Key Employees
Oryzon Genomics S.A. - Locations And Subsidiaries
Head Office
Recent Developments
Oryzon Genomics S.A., Recent Developments
Sep 19, 2014: ORYZON reinforces its Board of Directors
Sep 14, 2011: Oryzon Genomics To Launch GynEC Dx Non Invasive Test For Detection Of Endometrial Cancer
May 17, 2011: Geadic Biotec Presents Results From Clinical Validation Of GynEC-Dx Test At SSGO 2011
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Oryzon Genomics S.A., Key Facts
Oryzon Genomics S.A. Pipeline Products and Clinical Trials Overview
Oryzon Genomics S.A. Pipeline Products by Equipment Type
Oryzon Genomics S.A. Pipeline Products by Indication
Oryzon Genomics S.A., Key Facts
Oryzon Genomics S.A., Major Products and Services
Oryzon Genomics S.A. Number of Pipeline Products by Development Stage
Oryzon Genomics S.A. Pipeline Products Summary by Development Stage
Diagnostic Assay - Alzheimer's Disease - Product Status
Diagnostic Assay - Alzheimer's Disease - Product Description
Diagnostic Assay - Gastric Cancer - Product Status
Diagnostic Assay - Gastric Cancer - Product Description
Diagnostic Assay - Melanoma Cancer - Product Status
Diagnostic Assay - Melanoma Cancer - Product Description
Diagnostic Assay - Parkinson's Disease - Product Status
Diagnostic Assay - Parkinson's Disease - Product Description
Diagnostic Assay - Stomach Cancer - Product Status
Diagnostic Assay - Stomach Cancer - Product Description
Oryzon Diagnostic Test - Prostate Cancer - Product Status
Oryzon Diagnostic Test - Prostate Cancer - Product Description
Prognostic Assay - Gastric Cancer - Product Status
Prognostic Assay - Gastric Cancer - Product Description
Prognostic Assay - Melanoma Cancer - Product Status
Prognostic Assay - Melanoma Cancer - Product Description
Prognostic Assay - Ovarian Cancer - Product Status
Prognostic Assay - Ovarian Cancer - Product Description
Prognostic Test - Colorectal Cancer - Product Status
Prognostic Test - Colorectal Cancer - Product Description
Oryzon Genomics S.A., Key Employees

LIST OF FIGURES

Oryzon Genomics S.A. Pipeline Products by Equipment Type
Oryzon Genomics S.A. Pipeline Products by Development Stage
Skip to top


Ask Your Question

Oryzon Genomics S.A. - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: